Literature DB >> 17166914

Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.

Qinglin Li1, Robert Means, Sabine Lang, Jae U Jung.   

Abstract

Upon viral infection, the major defense mounted by the host immune system is activation of the interferon (IFN)-mediated antiviral pathway. In order to complete their life cycles, viruses must modulate the host IFN-mediated immune response. The K3 and K5 proteins of a human tumor-inducing herpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV), have been shown to downregulate the surface expression of host immune modulatory receptors by increasing their endocytosis rates, which leads to suppression of cell-mediated immunity. In this report, we demonstrate that K3 and K5 both specifically target gamma interferon receptor 1 (IFN-gammaR1) and induce its ubiquitination, endocytosis, and degradation, resulting in downregulation of IFN-gammaR1 surface expression and, thereby, inhibition of IFN-gamma action. Mutational analysis indicated that K5 appeared to downregulate IFN-gammaR1 more strongly than K3 and that the amino-terminal ring finger motif and the carboxyl-terminal region of K5 were necessary for IFN-gammaR1 downregulation. These results suggest that KSHV K3 and K5 suppress both cytokine-mediated and cell-mediated immunity, which ensures efficient viral avoidance of host immune controls.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166914      PMCID: PMC1865953          DOI: 10.1128/JVI.01961-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes.

Authors:  V Piguet; F Gu; M Foti; N Demaurex; J Gruenberg; J L Carpentier; D Trono
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein.

Authors:  T E Morrison; A Mauser; A Wong; J P Ting; S C Kenney
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

Review 3.  Viruses know it all: new insights into IFN networks.

Authors:  Hartmut Hengel; Ulrich H Koszinowski; Karl-Klaus Conzelmann
Journal:  Trends Immunol       Date:  2005-07       Impact factor: 16.687

4.  Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

Authors:  Mandana Mansouri; Janet Douglas; Patrick P Rose; Kristine Gouveia; Gary Thomas; Robert E Means; Ashlee V Moses; Klaus Früh
Journal:  Blood       Date:  2006-04-06       Impact factor: 22.113

5.  Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase.

Authors:  Ken Cadwell; Laurent Coscoy
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

Review 6.  On the role of IRF in host defense.

Authors:  Betsy Barnes; Barbora Lubyova; Paula M Pitha
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

7.  Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).

Authors:  L Burysek; W S Yeow; P M Pitha
Journal:  J Hum Virol       Date:  1999 Jan-Feb

8.  Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulence.

Authors:  Kevin A Cassady; Martin Gross; G Yancey Gillespie; Bernard Roizman
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein.

Authors:  Suzanne Fuld; Charles Cunningham; Kevin Klucher; Andrew J Davison; David J Blackbourn
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition.

Authors:  L Coscoy; D J Sanchez; D Ganem
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

View more
  59 in total

1.  Newly discovered viral E3 ligase pK3 induces endoplasmic reticulum-associated degradation of class I major histocompatibility proteins and their membrane-bound chaperones.

Authors:  Roger A Herr; Xiaoli Wang; Joy Loh; Herbert W Virgin; Ted H Hansen
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

Review 2.  Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Authors:  Hye-Ra Lee; Stacy Lee; Preet M Chaudhary; Parkash Gill; Jae U Jung
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.

Authors:  Cyprian C Rossetto; Gregory S Pari
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity.

Authors:  Donald W Lawrence; Jacki Kornbluth
Journal:  Cell Signal       Date:  2016-08-26       Impact factor: 4.315

6.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Kasinath Viswanathan; Janet L Douglas; Jennie Hines; Jean Gustin; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets.

Authors:  Ken Cadwell; Laurent Coscoy
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

9.  The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.

Authors:  Claire Pardieu; Raphaël Vigan; Sam J Wilson; Alessandra Calvi; Trinity Zang; Paul Bieniasz; Paul Kellam; Greg J Towers; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

10.  The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

Authors:  K M Shah; S E Stewart; W Wei; C B J Woodman; J D O'Neil; C W Dawson; L S Young
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.